SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING
1.2. Relevant identified uses of the substance or mixture and uses advised against
1.3. Details of the supplier of the safety data sheet
Helifix Ltd21 Warple WayLondonW3 0RXUKTel: +44 (0)20 8735 5200Fax: +44 (0)20 8735 5201Email: [email protected]
+44 (0)1773 540440 (Mon - Fri 08:00 - 16:00)
2.1. Classification of the substance or mixture
In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
After contact with skin, wash immediately with plenty of water.
Wear suitable protective clothing, gloves and eye/face protection.
Contains BENZOYL PEROXIDE. May produce an allergic reaction.
SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS
The Full Text for all R-Phrases and Hazard Statements are Displayed in Section 16.
InhalationMove the exposed person to fresh air at once. Get medical attention if any discomfort continues. IngestionNEVER MAKE AN UNCONSCIOUS PERSON VOMIT OR DRINK FLUIDS! Rinse mouth thoroughly. Get medical attention if any discomfort continues. Skin contactRemove affected person from source of contamination. Remove contaminated clothing. Wash the skin immediately with soap and water. Get medical attention if any discomfort continues. Eye contactImmediately flush with plenty of water for up to 15 minutes. Remove any contact lenses and open eyelids widely. If irritation persists: Seek medical attention and bring along these instructions.
4.2. Most important symptoms and effects, both acute and delayed
Inhalation. Irritation of nose, throat and airway. IngestionMay cause discomfort if swallowed. Skin contactMay cause skin irritation/eczema. Eye contactIrritation of eyes and mucous membranes.
4.3. Indication of any immediate medical attention and special treatment needed
No recommendation given, but first aid may still be required in case of accidental exposure, inhalation or ingestion of this chemical. If in doubt, GET MEDICAL ATTENTION PROMPTLY!
Extinguishing mediaExtinguish with foam, carbon dioxide or dry powder.
5.2. Special hazards arising from the substance or mixture
Hazardous combustion productsIn case of fire, toxic gases (CO, CO2, NOx) may be formed. Unusual Fire & Explosion HazardsNo unusual fire or explosion hazards noted.
Special Fire Fighting ProceduresAvoid breathing fire vapours. Protective equipment for fire-fightersSelf contained breathing apparatus and full protective clothing must be worn in case of fire.
6.1. Personal precautions, protective equipment and emergency procedures
Wear protective clothing as described in Section 8 of this safety data sheet.
Do not discharge into drains, water courses or onto the ground.
6.3. Methods and material for containment and cleaning up
Collect spillage in containers, seal securely and deliver for disposal according to local regulations.
Wear protective clothing as described in Section 8 of this safety data sheet. For waste disposal, see section 13.
Do not use in confined spaces without adequate ventilation and/or respirator.
7.2. Conditions for safe storage, including any incompatibilities
Store in tightly closed original container in a dry, cool and well-ventilated place. Flammable/combustible - Keep away from oxidisers, heat and flames. Storage ClassChemical storage.
The identified uses for this product are detailed in Section 1.2.
SECTION 8: EXPOSURE CONTROLS/PERSONAL PROTECTION
Engineering measuresProvide adequate ventilation. Observe Occupational Exposure Limits and minimise the risk of inhalation of vapours. Respiratory equipmentNo specific recommendation made, but respiratory protection may still be required under exceptional circumstances when excessive air contamination exists. Hand protectionProtective gloves are recommended. Eye protectionWear approved safety goggles. Other ProtectionWear appropriate clothing to prevent any possibility of skin contact.
Hygiene measuresDO NOT SMOKE IN WORK AREA! Wash hands at the end of each work shift and before eating, smoking and using the toilet. Wash promptly if skin becomes wet or contaminated. Promptly remove any clothing that becomes contaminated. Use appropriate skin cream to prevent drying of skin. When using do not eat, drink or smoke.
SECTION 9: PHYSICAL AND CHEMICAL PROPERTIES
9.1. Information on basic physical and chemical properties
Initial boiling point and boiling range 145.14Melting point (°C)
Vapour density (air=1)Not determined. Vapour pressurePaEvaporation rateNot determined. pH-Value, Conc. SolutionNot applicable. Viscosity
Solubility Value (G/100G [email protected]°C)Not applicable. Decomposition temperature (°C)Not determined. Odour Threshold, LowerNot determined. Odour Threshold, UpperNot determined. Flash point
Flammability Limit - Lower(%)Not determined. Flammability Limit - Upper(%)Not determined. Partition Coefficient (N-Octanol/Water)Not determined. Explosive propertiesNo information available. Oxidising propertiesDoes not meet the criteria for oxidising.
Reaction with: Organic peroxides/hydroperoxides.
Stable under normal temperature conditions.
None under normal conditions. Hazardous PolymerisationNot relevant
Avoid excessive heat for prolonged periods of time.
Materials To AvoidOrganic peroxides/hydroperoxides.
In case of fire, toxic gases (CO, CO2, NOx) may be formed.
11.1. Information on toxicological effects
InhalationIn high concentrations, vapours may irritate throat and respiratory system and cause coughing.
IngestionMay cause discomfort if swallowed.
Skin contactLiquid may irritate skin. Eye contactIrritating to eyes.
Toxicological information on ingredients.
Acute toxicity:Acute Toxicity (Oral LD50)> 2000 mg/kg Rat
EcotoxicityNot regarded as dangerous for the environment.
Ecological information on ingredients.
Acute Toxicity - FishLC50 96 hours 4 - 10 mg/lAcute Toxicity - Aquatic InvertebratesEC50 48 hours 4.7 mg/l Daphnia magna
Acute Toxicity - FishLC50 96 hours 0.06 mg/l Onchorhynchus mykiss (Rainbow trout)Acute Toxicity - Aquatic InvertebratesEC50 48 hours 0.11 mg/l Daphnia magnaAcute Toxicity - Aquatic PlantsEC50 72 hours 0.07 mg/l Selenastrum capricornutum
Bioaccumulative potentialNo data available on bioaccumulation. Partition coefficientNot determined.
Mobility:Not relevant, due to the form of the product.
This product does not contain any PBT or vPvB substances.
Residues and empty containers should be taken care of as hazardous waste according to local and national provisions. FLAMMABLE
Environmentally Hazardous Substance/Marine PollutantNo.
14.7. Transport in bulk according to Annex II of MARPOL73/78 and the IBC Code
15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture
Guidance NotesWorkplace Exposure Limits EH40. EU LegislationRegulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 with amendments. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC, including amendments.
No chemical safety assessment has been carried out.
Revision CommentsNOTE: Lines within the margin indicate significant changes from the previous revision. Revision Date
Extreme risk of explosion by shock, friction, fire or other sources of ignition.
May cause sensitisation by skin contact.
Heating may cause a fire or explosion.
May cause an allergic skin reaction.
This information relates only to the specific material designated and may not be valid for such material used in combination with any other materials or in any process. Such information is, to the best of the company's knowledge and belief, accurate and reliable as of the date indicated. However, no warranty guarantee or representation is made to its accuracy, reliability or completeness. It is the user's responsibility to satisfy himself as to the suitability of such information for his own particular use.
CNS Muscle Relaxants Clinical Pearls for the Washington Rx Therapeutic Interchange Program (TIP) Steve Riddle, BS Pharm, BCPS Background In 2003, the Washington State Pharmacy and Therapeutics Committee (P&T), the agency directors of the Department of Social and Health Services-Medical Assistance Administration (DSHS-MAA), Labor and Industries (L&I), and the Health Care
[ The Indian Practitioner (1973): 8, 395] Liv.52 in the Treatment of Acute Infective Hepatitis Sarkar, M.K., M.B.,B.S. Medical Officer-in-charge, Burn & Co., Durgapur, Burdwan, India. Many drugs have been tried for the therapy of acute infective hepatitis. Chemotherapeutic agents and antibiotics have been demonstrated to be of little use. Those, which are known to be inactiv